Enable Cheminformatics and Bioinformatics in Microsoft Office
Cambridge, MA: Scilligence, a leading innovator of scientific software solutions, is thrilled to unveil HELM technology in TouchMol4Office (TM4O).
TM4O represents an advancement in the realm of cheminformatics and bioinformatics within the Microsoft Office suite, providing researchers and professionals with a comprehensive platform for interfacing with internal and external databases while working seamlessly in applications like Excel, Word, and PowerPoint.
TM4O empowers users with powerful structure search capabilities, advanced informatics for biologics and conjugates, and now HELM support making it an indispensable tool for professionals working in the fields of chemistry, biology, and pharmaceuticals.
Empowering Chem-Bioinformatics within MS Office Unleash the potential of MS Office with seamless integration of advanced chem-bioinformatics capabilities. This groundbreaking enhancement opens up a world of possibilities for professionals in the scientific and research communities.
Harnessing Macromolecules through HELM Embrace the future of scientific research with MS Office’s built-in support for macromolecules by utilizing HELM. Additionally, you have the option to integrate HELMmonomer.org, unlocking access to exclusive HELM monomer libraries and taking your research to new heights.
Effortless Integration with Back-End Databases Breakdown data silos and improve your research efficiency with TM4O’s ability to seamlessly connect with back-end databases. Now, you can effortlessly convert CAS numbers and registration IDs into molecular structures from diverse data sources, streamlining your workflow like never before.
With the enablement of HELM in TM4O, Scilligence aims to allow scientists to easily and quickly create complex macromolecules by using an industry-standard notation, making it an indispensable asset for researchers, scientists, and professionals across various industries.
“TouchMol4Office with the enablement of HELM technology will empower scientists to explore a wide variety of therapeutics modalities right inside Microsoft Office applications, a daily staple in research environments”, says Jinbo Lee, PhD, CEO at Scilligence Corporation.
ELN for Academic Research: A Success Story
September 11, 2023
The Problems with Paper Notebooks
“Hey, I think someone ran that reaction a few years ago, why don’t you go check in their notebook?”
Have you heard this request from your PI and immediately thought…
Yeah. I’ve been there.
I remember thinking even if I managed to find the right page, I would have to undertake a second and equally arduous journey to find the associated NMR spectra and other characterization data.
Safe to say that in the digital age… Data is King
The ability to digitally store, share, mine, and process data is the foundation of how we work today. So why as chemists and biologists in academia are we continuing to confine our most valuable data, our experimental records, to paper notebooks on neglected shelves, the same way scientists have done since the 19th century?
In the age of database searches, word processing, file sharing, and email surely there must be a way to digitize the scientific process?
These were the questions being asked in Prof. Shih-Yuan Liu’s Research Group at Boston College in 2015 when we decided to start the search for an electronic lab notebook (ELN).
The ELN Solution: Digital Notebook, Searchable Database
Aside from a searchable data repository for all our reactions, there were other features motivating us to make the jump from paper to digital. We were looking for a way to standardize lab notebook entries to improve record keeping and a platform that would encourage collaboration and information sharing.
Most organic chemists are familiar with the software ChemDraw®, the chemical sketcher tool; we knew that having a similar sketcher in a digital notebook entry would save a lot of time over hand-drawing reaction schemes. Organic chemists often run the same or similar reactions multiple times, therefore having the ability to copy or refer to experiments would be very useful.
In a paper notebook, the lack of a copy-paste feature fosters some poor record-keeping habits, such as certain lab member’s tendency to just write “see page XX” instead of filling in crucial reaction details for a repeated reaction.
While the benefits of features like copy-paste seemed pretty straight-forward, we did not have a sense of the life-changing improvements adopting an ELN would bring prior to starting our evaluations.
Here are the three important lessons I learned about finding ELN that is right for my lab:
1) Use the ELN as if it were already your notebook! While it takes more effort, the only way to put an ELN through its paces is to record real experiments with real data. A few days of using an ELN provided a good picture of how it would fare over the next few years.
2) No ELN is perfect! Just like with any software, there will be some quirks and features that not all users will like. Decide as a group what aspects of the software are simply inconvenient and which ones are deal breakers.
3) Change is difficult! Adopting a new piece of software or learning how to use any new tool can be a challenging process. Be patient, stick with it, and form a consensus on how the new software will be implemented.
Following our review process, the Scilligence ELN became our ELN of choice with its combination of an excellent search feature, convenience, time saving tools such as copy experiments, reagent lookup, direct integration with NMR, robust performance, and competitive price point.
The Scilligence team worked closely with us to deploy their web-based software, trained us on how to use it, and applied a few customizations.
A few months after we started our search for an ELN, we bid farewell to paper notebooks!
Experiencing the benefits of adopting the Scilligence ELN right off the bat!
Several features of the Single Step Reaction form, an ideal template for synthetic organic chemistry experiments, significantly reduced data entry time. The reaction scheme editor populates reagents from a database search, simultaneously pulling in key information like MW and MF. The stoichiometry table automatically calculates amounts and ratios. After the software does most of the heavy lifting by filling in the reaction scheme data, generating a procedure is even more straightforward.
With the recipe feature, a scientist can generate a generalized experiment template and share it with the whole group; the recipe pulls in reagent information, leaving only a few minor adjustments to be made.
In addition to saving time for individual notebook entries, the ELN makes information sharing much more efficient. Our group used the project documents as a central location for sharing references, SOP’s, presentations and other group project materials. Before the ELN, we had to recreate all our paper reaction schemes in ChemDraw® and then paste them into PowerPoint slides for group meetings. Using the ELN allowed us to start holding group meetings and presentations right in the ELN environment, with researchers projecting their notebook pages on a presentation screen.
Professor Liu could now monitor the entire groups’ notebooks from the comfort of his own desk!
I experienced the greatest impact of using the Scilligence ELN when it came time to write my thesis.
Instead of having to dig through instrument computers to track down data, process that raw analytical data into spectra, and chase down that one reaction with the highest yield, all my data was already present in a centralized, fully searchable database.
I defended my PhD thesis at Boston College in May 2019 and went on to work in materials research at a government contractor. This year I returned to Scilligence as an employee, working as an Application Scientist in Presales Support. The Boston College Chemistry Department continues to use Scilligence ELN and to build an ever-expanding database that will be far more valuable to researchers than forgotten notebooks on dusty shelves!
Scilligence is working on an ELN catered to academic institutions so that more student researchers can access the tremendous benefits of a digital scientific workflow. This ELN will streamline the lab notebook experience and encourage collaboration by providing a digitized and paperless way to work on experiments and projects at every step. Browse experiments across multiple notebooks, harmonize the format of data content, quickly search for specific information, and prevent the loss of existing laboratory knowledge when researchers leave.
Scilligence partners with Chemical.ai to co-develop ELN-based data integration
June 13th, 2022
Chemical.AI-Scilligence Launched their Strategic Cooperation to Co-develop ELN-based Data Integration
Chemical.AI, a high-tech company empowering chemistry with AI and ML, announced a strategic partnership with Scilligence, a web-based informatics solution provider for R&D. The two parties will co-develop high-efficiency data integration on Scilligence’s ELN with Chemical.AI’s leading AI-empowered route design systems (Retrosynthesis, forward synthesis, synthetic accessibility score, etc.), in a bid to enable Scilligence’s ELN users to search and utilize the data in their ELNs and molecular building block libraries with Chemical.AI’s route design systems.
Organic synthesis plays a key role in the R&D fields of pharmaceuticals, new materials, chemicals and other related industries. In the past, because of the diversity and complexity of organic reactions, the efficiency of organic synthesis strongly relied on chemists’ knowledge and expertise which is difficult to improve. Chemical.AI’s unique AI-aided route design systems can provide chemists with novel, feasible, and diversified synthetic routes. By helping them search and reuse internal data and experiences, such as ELNs and BB libraries, chemists can save their exploration time and broaden their skill-set. Scilligence’s ELN aimes to significantly strengthen internal teamwork, knowledge sharing, and information management of pharmaceutical enterprises and enhance their R&D outputs. The data integration of Chemical.AI’s route design systems into Scilligence’s ELN will significantly enhance the R&D efficiency of organic synthesis and its related industries.
“Nowadays, AI has gradually penetrated nearly every field of our lives and work, and computer application programs based on big data and artificial intelligence are starting to show great potential in assisting researchers in chemical synthesis route design.” Said Dr. Ning Xia, founder and CEO of Chemical.AI, “We are pleased to collaborate with Scilligence to develop ELN-based data integration to leverage our respective strengths to further advance data reuse, knowledge sharing, and research innovation, accelerate the application of data integration in the pharmaceutical R&D process and realize win-win cooperation.”
“Only by leveraging the most cutting-edge and practical informatics research and development can we effectively promote scientific output in the biomedical field. We hope to have more opportunities to integrate our solutions more deeply into user workflows to enhance the efficiency of scientific research activities. Scilligence is pleased to collaborate deeply with Chemical.AI in data integration based on ELN to automate, accelerate and intelligentize chemical synthesis and drug R&D.” Said Jinbo Lee, CEO of Scilligence.
About Chemical.AI
Chemical.AI, an R&D technology company empowering chemistry with AI that uses artificial intelligence technology, chemical big data and machine learning to develop toolkit that dramatically improves the efficiency of chemical research, is committed to building an intelligent planning platform for compounds to reshape the future of chemistry.
Chemical.AI was founded in Wuhan in 2018, and its subsidiary, Shanghai Chemiscal Biotech Co., Ltd. was established in 2021, aiming to provide intelligent and automotive synthesis service. Chemical.AI’s team consists of cheminformatics specialists, chemical synthesis experts and talented IT professionals. Up to now, Chemical.AI has successfully provided technical services for many famous pharmaceutical companies and CROs at home and abroad, and has launched in-depth cooperation in the directions of synthetic route design, process route design, synthetic service, etc.
About Scilligence
Scilligence is an innovation leader of web-based cheminformatics and bioinformatics solutions for life sciences R&D. The Scilligence system is built with proprietary technologies to support both biologics and small molecules in a unified platform, making it a flexible solution for a variety of research workflows. Scilligence’s informatics solutions include a variety of modules for data management that can be utilized as separate applications or as a fully integrated system. Its tools have been widely adopted by pharmaceutical, biotech and chemical industries, universities, research institutes, and government agencies. Scilligence is the developer of the HELM (Hierarchical Editing Language for Macromolecules) Web Editor which works to further standardize HELM notation and facilitate the exchange of information between researchers.
Scilligence Partners with CAS to Optimize R&D Informatics Workflows with Scientist-Curated Data
November 17, 2020
Scilligence Partners with CAS to Optimize R&D Informatics Workflows with Scientist-Curated Data
Scilligence, a provider of web-based informatics solutions for R&D, has partnered with CAS, a division of the American Chemical Society, to enable direct access to CAS scientific content through the Scilligence informatics platform. A previous partnership between Scilligence and CAS enabled users to initiate SciFindern searches directly from Scilligence ELN (Electronic Laboratory Notebook). This new partnership builds on the previous collaboration by streamlining additional workflow scenarios. Users can now access the human-curated CAS REGISTRY® directly from Scilligence ELN and Scilligence Inventory.
“We are excited about our second partnership with CAS. Integration of Scilligence informatics solutions with CAS content will help scientists to query and access CAS’s scientific content with more efficiency. This is an outstanding example of practicing FAIR data principles and removing data silos,” said Jinbo Lee, Chief Scientific Officer and co-founder of Scilligence.
Scilligence ELN with CAS and Scilligence Inventory with CAS are currently available with additional integrations coming in 2021 across the portfolio of products, including RegMol with CAS and TouchMol4Office with CAS. Through this integration, Scilligence users will have the ability to search for substances from CAS REGISTRY in the research workflow. CAS provides the largest and most up-to-date collection of scientific information including CAS REGISTRY, the gold standard for disclosed chemical information in the world.
“Embedding our scientist-curated data directly within Scilligence solutions will provide researchers with access to authoritative chemical names and structure data, giving them access to critical resources within their R&D workflows. This partnership is an important step to increase productivity, knowledge sharing and innovation in research,” said Andrea Jacobs, Senior Product Manager for Partnerships, CAS.
About CAS
CAS, a division of the American Chemical Society, is a specialist in scientific information that supports innovation-focused organizations globally. For over a century, CAS products and services have enabled scientific insights to help organizations plan, innovate, protect their innovations, and hypothesize new opportunities. Built on the foundation of the CAS content collection, CAS solutions support research, patent, regulatory, and business professionals in scientific research and development. www.cas.org
About Scilligence
Scilligence is an innovation leader of web-based cheminformatics and bioinformatics solutions for life sciences R&D. The Scilligence system is built with proprietary technologies to support both biologics and small molecules in a unified platform, making it a flexible solution for a variety of research workflows. Scilligence’s informatics solutions includes a variety of modules for data management that can be utilized as separate applications or as a fully integrated system. Its tools have been widely adopted by pharmaceutical, biotech, and chemical industries, universities, research institutes, and government agencies. Scilligence is the developer of the HELM (Hierarchical Editing Language for Macromolecules) Web Editor which works to further standardize HELM notation and facilitate the exchange of information between researchers. www.scilligence.com
In collaboration with Pistoia Alliance, Scilligence will be launching Monomer.org, a web-based platform for monomer libraries and a viewer that can interpret macromolecules expressed in a HELM string. The site, set to become available to the public in fall of 2020, will provide the scientific community with the following services:
A well-researched and curated core monomer set to ease the deployment of the HELM ISO standard
A secure platform to manage and share monomer libraries internally and externally
A web portal to visualize macromolecules expressed in a HELM string
An introduction and demo to this project will be presented by Scilligence and Pistoia Alliance during our fall workshop, R&D Informatics for Special Modalities, on October 14th.
Scilligence Gives Back During the COVID-19 Pandemic
While streets and stores may be empty during the COVID-19 outbreak, our hospitals are over capacity. The COVID-19 pandemic has resulted in an increase in patients and massive shortage in supplies for healthcare workers. The world is currently facing a chronic shortage of personal protective equipment (PPE). One of these items that hospitals are in dire need of are face masks to protect workers from airborne particles. Doctors and nurses have been forced to improvise with other items because they don’t have access to proper kits.
Scilligence has responded to this need by donating 10,080 N95 face masks to the Cambridge Health Alliance. These masks help protect our healthcare heroes by providing proper filtration and facial fit to aid against contracting the novel coronavirus. Scilligence had the masks, made in the USA, shipped from overseas.
“Their amazing gift of over 10,000 N95 masks is a critical component of our strategy to provide the greatest possible protection to our healthcare workers throughout the entire arc of this crisis.”Jill Batty, Senior Vice President and CFO of Cambridge Health Alliance.
Scilligence is proud to be able to help support our community during these critical times. “We are saddened by the continued loss of life in this COVID-19 crisis. This virus doesn’t distinguish between borders or race, especially endangering our healthcare workers at the frontline of this global struggle. The donation of high-quality N95 masks to our medical community is the least we can do as a Boston-based company”, said Dr. Jinbo Lee, Chief Scientific Officer of Scilligence Corporation. “CHA is extremely grateful for the prompt and generous outreach from Tony Yuan, Scilligence Director of R&D. This company immediately recognized the need for the Cambridge community to pull together to prepare for the COVID19 pandemic. Their amazing gift of over 10,000 N95 masks is a critical component of our strategy to provide the greatest possible protection to our healthcare workers throughout the entire arc of this crisis. Scilligence’s willingness to step forward is a wonderful example of community stewardship during this time of crisis for the vulnerable populations CHA serves.”, said Jill Batty, Senior Vice President and CFO of Cambridge Health Alliance.
As we continue to fight this outbreak, it is important to keep in mind what we can do as groups and individuals to help this crisis come to resolution. Following guidelines and staying in unless absolutely essential is key at this time. Scilligence employees are currently working from home and assisting customers remotely. Our donation to Cambridge Health Alliance and remote efforts are a small but important part in our efforts to help end the COVID-19 pandemic.
Scilligence and CAS Collaborate to Integrate SciFinder with ELN
CAS, a division of the American Chemical Society, partnered with Scilligence to integrate SciFindern with Scilligence ELN (Electronic Laboratory Notebook). This integration helps scientists simplify their workflow by allowing easy access to vital research information in SciFindern and maintaining traceability of their ideas. Structure and reaction searches in the SciFindern content collection can be initiated directly from Scilligence ELN.
“Reference-to-idea traceability has always been a challenge for researchers due to the cumbersome nature of keeping track of reference information. As SciFindern is the leading solution used by scientists globally to search the scientific literature, the integration of SciFindern with Scilligence ELN makes this task easier for scientists, saving time and increasing productivity”, said Jinbo Lee, Chief Scientific Officer and co-founder of Scilligence
Integration of SciFindern with Scilligence ELN provides various search options directly from Scilligence ELN. Researchers can search by reaction, patent Markush, reference, substance, and supplier. Advanced algorithms developed by CAS scientists and technologists allow researchers to search smarter and find answers faster, accelerating research. The application allows users to open multiple result sets at once, and extensive filtering and Boolean search options in SciFindern help users quickly find the most relevant results.
With the SciFindern integration, scientists will have access to all the relevant information associated with their experiment within Scilligence ELN, which includes a variety of experimental templates. Users can quickly access all of the data within SciFindern with a click of a button directly from Scilligence ELN.
“CAS is committed to the continuous enhancement of scientists’ experience with SciFindern and CAS content. We welcome opportunities to more deeply integrate our solutions into our customers’ workflows to improve the effectiveness of their daily activities. The integration of SciFindern with Scilligence ELN accomplishes this by eliminating additional steps in our users’ workflow, providing actionable information more quickly and efficiently”, said Tim Wahlberg, Vice President of Product Management at CAS.
The SciFindern content collection includes millions of references, substances, reactions, properties and suppliers. Users can search references and patents with text and keywords. Substances and reactions can be searched as drawn, by substructure, and by similarity. Substances include both organic and inorganic as well as protein and nucleic acid sequences. The integration supports both single and multi-step reactions. Suppliers can be searched as drawn and include catalog items and CAS Registry Numbers®. Users have the ability to use the Markush search to find location, filter by patent office, and access the PatentPak® viewer.
The integration will greatly benefit researchers by giving them direct access to patent documents, step-by-step synthetic procedures and methods, and product yields right from their ELN. Researchers will be able to make better decisions with relevant knowledge and insights. CAS and Scilligence are proud to be part of a project that enhances workflows for scientists and ultimately accelerates research and look forward to further developing the integration’s features.
About CAS
CAS, a division of the American Chemical Society, partners with R&D organizations globally to provide actionable scientific insights that help them plan, innovate, protect their innovations, and predict how new markets and opportunities will evolve. Scientific researchers, patent professionals and business leaders around the world across commercial, academic and government sectors rely on our solutions and services to advise discovery and strategy. Leverage our unparalleled content, specialized technology, and unmatched human expertise to customize solutions that will give your organization an information advantage. With more than 110 years’ experience, no one knows more about scientific information than CAS. Learn more at www.cas.org.
About Scilligence
Scilligence is an innovation leader of web-based cheminformatics and bioinformatics solutions for life sciences R&D. The Scilligence system is built with proprietary technologies to support both biologics and small molecules in a unified platform, making it a flexible solution for a variety of research workflows. Scilligence’s informatics solutions includes a variety of modules for data management that can be utilized as separate applications or as a fully integrated system. Its tools have been widely adopted by pharmaceutical, biotech, and chemical industries, universities, research institutes, and government agencies. Scilligence is the developer of the HELM (Hierarchical Editing Language for Macromolecules) Web Editor which works to further standardize HELM notation and facilitate the exchange of information between researchers. www.scilligence.com
Scilligence Media Contact Krystyana Roman [email protected] +1 (617) 520-4588
Scilligence and Certara Partner to Improve Client’s Data Analysis and Visualization
December 5, 2019
Scilligence, an innovation leader of unified informatics platform for biologics and small molecules drug R&D, has partnered with Certara to enable advanced data analysis and visualization capabilities. The companies worked together to integrate Certara’s D360 with Scilligence’s RegMol system. The partnership will help current and future clients to better visualize their scientific research data.
Scilligence provides an integrated platform for life science R&D. Scilligence’s RegMol is a web-based system for modality (small molecules, biologics, and conjugates) registration and bioassay database. Certara’s D360 provides scientists with multi-source data access tightly coupled with analysis and data visualization tools to allow efficient data-driven decision making; one click access to project data views and ad hoc data mining.
“We are very excited about the seamless integration of RegMol with D360, which provides our clients advanced data analysis and visualization options without the need of manually exporting and importing data”, said Jinbo Lee, Chief Scientific Officer and co-founder of Scilligence.
The Scilligence-Certara partnership benefits companies in drug discovery working with small molecules and biologics. By integrating their systems, the companies can improve efficiency and reduce data silos for researchers. Scilligence and Certara look forward to continuing their partnership and exploring other areas of collaboration.
“Integration of D360 with Scilligence’s data systems allows our mutual customers to both capture and analyze research data with unprecedented efficiency allowing real-time research decision making. The creation of a standard Scilligence connector for D360 allows rapid, simple deployment of a best-of-breed system that supports research with a minimum of maintenance overhead.” said David Lowis, Senior Director of Product Management at Certara
About Scilligence
Scilligence is an innovation leader of web-based cheminformatics and bioinformatics solutions for life sciences R&D. The Scilligence system is built with proprietary technologies to support both biologics and small molecules in a unified platform, making it a flexible solution for a variety of research workflows. Scilligence’s informatics solutions includes a variety of modules for data management that can be utilized as separate applications or as a fully integrated system. Its tools have been widely adopted by pharmaceutical, biotech, and chemical industries, universities, research institutes, and government agencies. Scilligence is the developer of the HELM (Hierarchical Editing Language for Macromolecules) Web Editor which works to further standardize HELM notation and facilitate the exchange of information between researchers. www.scilligence.com
About Certara Certara is the global leader in advancing modern, efficient drug development. Certara provides proven modeling & simulation, regulatory science, and scientific value assessment software and services to help clients reduce clinical trial burden, accelerate regulatory approval, and increase patient access to medicines. www.certara.com
Zifo RnD Solutions and Scilligence Announce Strategic Partnership
Zifo RnD Solutions and Scilligence Corporation announce a strategic partnership that enables Zifo to provide System Integrations Solutions for Scilligence suite of integrated informatics solutions. The partnership will help clients to easily select, evaluate, and implement solutions that fit their research needs.
Scilligence provides the scientific community with powerful tools to mine and manage data collected in labs. Zifo will complement Scilligence by providing technology services to make different systems seamlessly connect to each other. This will ensure uninterrupted flow of data between systems, helping scientists save valuable time.
“We are excited to work together with Scilligence and strongly believe the value addition we can provide together to the end user would be tremendous,” said Raj Prakash, CEO and Co-Founder of Zifo RnD Solutions.
“The Zifo team has done an excellent job supporting Scilligence’s informatics platform at a few big pharma and large biotech companies. This partnership will strengthen our collaborations and enhance quality of informatics services to life science community,” said Jinbo Lee, CSO and Co-Founder of Scilligence Corporation.
About the Partners Scilligence is an innovation leader of web-based cheminformatics and bioinformatics solutions for both small molecules and biologics. As the developer of the HELM (Hierarchical Editing Language for Macromolecules) Web Editor, Scilligence works with Pistoia Alliance to further standardization of HELM notation for macromolecules. Scilligence’s one-stop-shop for R&D informatics needs includes a variety of modules for data management that can be utilized as separate applications or as a fully integrated system. Its tools have been widely adopted by pharmaceutical, biotech, and chemical industries, universities, research institutes, and government agencies. Visit: www.scilligence.com to learn more.
Zifo RnD Solutions is a fast-growing global organization with offices in US, UK, India, France, China and Japan. Zifo RnD Solutions helps organizations strategize, design, implement and support their systems by providing solutions in Laboratory Informatics, Scientific Data Management, Clinical Biometrics, Genome Informatics and Compliance Solutions.
Zifo works with customers from more than 20 countries, including 7 of the Top 10 global Bio-Pharmas. It has been ranked as one of the Fastest Growing Technology Companies for 7 consecutive years (2012 – ’18) by Deloitte, and has been recognized as one of the Best Companies to Work For in India 2016 by the Great Place to Work Institute and as one of India’s Great Mid-Size Workplaces – 2017, 2018 & 2019 – A study conducted by Great Place to Work® Institute India. Visit: www.zifornd.com to learn more.
HitGen has Licensed Scilligence’s ELN and RegMol
From the inception of the company, HitGen has been utilizing Scilligence’s Electronic Laboratory Notebook (ELN) and RegMol (Registration and BioAssay) system to capture and manage the large volume of DEL (DNA-encoded libraries) and their drug discovery project data.
“I was very impressed by the CEO of HitGen Dr. Jin Li’s vision that he would establish an integrated informatics platform before the first data point was generated at his company”, said Dr. Jinbo Lee, CSO of Scilligence Corporation.
“Scilligence provided HitGen an effective data management system in the early days of company’s development history, which has been useful in supporting our research activities”, said Dr. Jin Li, CEO of Hitgen.
About HitGen
HitGen is an integrated drug discovery company focused on the on the design, synthesis, and screening of DNA encoded chemical libraries (DELs). HitGen’s DELs contain over 400 billion novel, diverse, drug-like small molecule and macrocyclic compounds. These compounds are members of DELs synthesized from many hundreds of distinct chemical scaffolds, designed with tractable chemistry, and yielded proven results for the discovery of small molecule leads against precedented and unprecedented classes of biological targets.
About Scilligence
Scilligence is a leading innovator of web-based cheminformatics and bioinformatics solutions designed for any device, browser, and platform. Scilligence’s tools enhance the knowledge sharing and productivity of researchers in discovery and development of small molecule and biologic therapeutics.
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
Cookie
Duration
Description
cookielawinfo-checkbox-analytics
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional
11 months
The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance
11 months
This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
viewed_cookie_policy
11 months
The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
